References
3Arts Entertainment. Salt in My Soul. United States: 2022.
Antimicrobial Resistance Collaborators. 2022. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 399(10325):629–655. https://doi.org/10.1016/S0140-6736(21)02724-0.
Banerjee, R., L. Komarow, A. Virk, N. Rajapakse, A. N. Schuetz, B. Dylla, M. Earley, J. Lok, P. Kohner, S. Ihde, N. Cole, L. Hines, K. Reed, O. B. Garner, S. Chandrasekaran, A. de St Maurice, M. Kanatani, J. Curello, R. Arias, W. Swearingen, S. B. Doernberg, and R. Patel. 2021. Randomized trial evaluating clinical impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN. Clinical Infectious Diseases 73(1):e39–e46. https://doi.org/10.1093/cid/ciaa528.
Banerjee, R., C. B. Teng, S. A. Cunningham, S. M. Ihde, J. M. Steckelberg, J. P. Moriarty, N. D. Shah, J. N. Mandrekar, and R. Patel. 2015. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clinical Infectious Diseases 61(7):1071–1080. https://doi.org/10.1093/cid/civ447.
BARDA (Biomedical Advanced Research and Development Authority). 2022. BARDA announces the 64th FDA Approval/Licensure/Clearance for Simplexa™ COVID-19 Direct, the second standalone FDA cleared COVID-19 diagnostic test and supported by BARDA under Novel Public Private Partnerships. https://www.medicalcountermeasures.gov/newsroom/2022/simplexa/#:~:text=BARDA%20announces%20the%2064th%20FDA,under%20Novel%20Public%20Private%20Partnerships (accessed January 25, 2023).
BD (Becton, Dickinson and Company). 2022. Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices. https://investors.bd.com/news-releases/news-release-details/bd-pfizer-wellcome-collaborate-improve-global-hospital (accessed March 6, 2023).
Boehme, C. C., P. Nabeta, D. Hillemann, M. P. Nicol, S. Shenai, F. Krapp, J. Allen, R. Tahirli, R. Blakemore, R. Rustomjee, A. Milovic, M. Jones, S. M, O’Brien, D. H. Persing, S. Ruesch-Gerdes, E. Gotuzzo, C. Rodrigues, D. Alland, and M. D. Perkins. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. New England Journal of Medicine 363(11):1005–1015. https://doi.org/10.1056/NEJMoa0907847.
Buchan, B. W., S. Windham, J. M. Balada-Llasat, A. Leber, A. Harrington, R. Relich, C. Murphy, J. Dien Bard, S. Naccache, S. Ronen, A. Hopp, D. Mahmutoglu, M. L. Faron, N. A. Ledeboer, A. Carroll, H. Stone, O. Akerele, K. Everhart, A. Bonwit, C. Kwong, R. Buckner, D. Warren, R. Fowler, S. Chandrasekaran, H. Huse, S. Campeau, R. Humphries, C. Graue, and A. Huang. 2020. Practical comparison of the BioFire FilmArray Pneumonia Panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections. Journal of Clinical Microbiology 58(7):e00135-20. https://doi.org/10.1128/JCM.00135-20.
Burgess, D. H., J. Wasserman, C. A. Dahl, F. Girosi, S. S. Olmsted, E. B. Keeler, Y. Lim, J. E. Aledort, M. E. Rafael, K. A. Ricci, R. Boer, L. H. Hilborne, K. P. Derose, M. Shea, C. Beighley, M. Steinhoff, D. Holtzman, H. Campbell, R. Black, K. Mulholland, A. Ronald, S. M. Le Blancq, R. Ridzon, A. Landay, J. Safrit, R. W. Peeling, N. Hellmann, P. Mwaba, K. Holmes, C. M. Wilfert, P. I. Tarr, C. Mason, M. Miller, J. Hughes, L. von Seidlein, J. M. Agosti, R. L. Guerrant, T. Taylor, A. Magill, R. Allan, M. D. Perkins, P. Small, C. Hanson, S. Reed, J. Cunningham, C. Dye, P. Vickerman, M. Urdea, L. A. Penny, M. Y. Giovanni, P. Kaspar, A. Shepherd, P. Wilson, S. Buchsbaum, and G. Moeller. 2007. Estimating the Global Health Impact of Improved Diagnostic Tools for the Developing World. Santa Monica, CA: RAND Corporation. https://www.rand.org/pubs/research_briefs/RB9293.html (accessed January 23, 2023).
CDC (Centers for Disease Control and Prevention). 2019a. Antibiotic Resistance Threats in the United States, 2019. http://dx.doi.org/10.15620/cdc:82532 (accessed February 1, 2023).
CDC. 2019b. Sexually Transmitted Disease Surveillance 2018. http://dx.doi.org/10.15620/cdc.79370 (accessed February 1, 2023).
Centers for Medicare and Medicaid Services. 2023. “Clinical Laboratory Fee Schedule, File no. 23CLABQ1.” https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Clinical-Laboratory-Fee-Schedule-Files (accessed March 10, 2023).
Chou, E. H., S. Mann, T. C. Hsu, W. T. Hsu, C. C. Liu, T. Bhakta, D. M. Hassani, and C. C. Lee. 2020. Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: A nationwide study. PloS ONE 15(1):e0227752. https://doi.org/10.1371/journal.pone.0227752
Dhingra, S., N. A. A. Rahman, E. Peile, M. Rahman, M. Sartelli, M. A. Hassali, T. Islam, S. Islam, and M. Haque. 2020. Microbial resistance movements: An overview of global public health threats posed by antimicrobial resistance, and how best to counter. Frontiers in Public Health 8:535668. https://doi.org/10.3389/fpubh.2020.535668.
Evans, N. G., K. Hills, and A. C. Levine. 2020. How should the WHO guide access and benefit sharing during infectious disease outbreaks?. AMA Journal of Ethics 22(1):E28–E35. https://doi.org/10.1001/amajethics.2020.28
FDA (U.S. Food and Drug Administration). 2022. FDA Roundup: October 7, 2022. https://www.fda.gov/news-events/press-announcements/fda-roundup-october-7-2022 (accessed January 26, 2023).
Fidler, D. P. 2008. Influenza virus samples, international law, and global health diplomacy. Emerging Infectious Diseases 14(1):88–94. https://doi.org/10.3201/eid1401.070700.
Fleming, K. A., S. Horton, M. L. Wilson, R. Atun, K. DeStigter, J. Flanigan, S. Sayed, P. Adam, B. Aguilar, S. Andronikou, C. Boehme, W. Cherniak, A. N. Cheung, B. Dahn, L. Donoso-Bach, T. Douglas, P. Garcia, S. Hussain, H. S. Iyer, M. Kohli, A. B. Labrique, L. M. Looi, J. G. Meara, J. Nkengasong, M. Pai, K. L. Pool, K. Ramaiya, L. Schroeder, D. Shah, R. Sullivan, B. S. Tan, and K. Walia. 2021. The Lancet Commission on diagnostics: Transforming access to diagnostics. Lancet 398(10315):1997–2050. https://doi.org/10.1016/S0140-6736(21)00673-5.
Gandhi, T. K., A. Kachalia, E. J. Thomas, A. L. Puopolo, C. Yoon, C., T. A. Brennan, and D. M. Studdert. 2006. Missed and delayed diagnoses in the ambulatory setting: A study of closed malpractice claims. Annals of Internal Medicine 145(7):488–496. https://doi.org/10.7326/0003-4819-145-7-200610030-00006.
GISAID (Global Initiative on Sharing Avian Influenza Data). 2023. GISAID. https://gisaid.org/ (accessed January 26, 2023).
Gotham, D., L. McKenna, S. Deborggraeve, S. Madoori, and D. Branigan. 2021. Public investments in the development of GeneXpert molecular diagnostic technology. PloS ONE 16(8):e0256883. https://doi.org/10.1371/journal.pone.0256883.
Havers, F., S. Thaker, J. R. Clippard, M. Jackson, H. Q. McLean, M. Gaglani, A. S. Monto, R. K. Zimmerman, L. Jackson, J. G. Petrie, M. P. Nowalk, K. K. Moehling, B. Flannery, M. G. Thompson, and A. M. Fry. 2014. Use of influenza antiviral agents by ambulatory care clinicians during the 2012–2013 influenza season. Clinical Infectious Diseases 59(6):774–782. https://doi.org/10.1093/cid/ciu422.
Health Council of the Netherlands. 2007. MRSA Policy in the Netherlands. The Hague: Health Council of the Netherlands. https://www.healthcouncil.nl/documents/advisory-reports/2006/10/16/mrsa-policy-in-the-netherlands (accessed January 22, 2023).
Hunt, J. M., G. D. Roberts, L. Stockman, T. A. Felmlee, and D. H. Persing. 1994. Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens. Diagnostic Microbiology and Infectious Disease 18(4):219–227. https://doi.org/10.1016/0732-8893(94)90024-8.
IOM (Institute of Medicine). 2010. Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary. Washington, DC: The National Academies Press. https://doi.org/10.17226/12925.
Jin, S., J. Y. Lee, J. Y. Park, and M. J. Jeon. 2020. Xpert Carba-R assay for detection of carbapenemase-producing organisms in patients admitted to emergency rooms. Medicine 99(50):e23410. https://doi.org/10.1097/MD.0000000000023410.
Kenigsberg, B. 2022. “‘Salt in My Soul’ review: Living, even thriving, with illness”. New York Times. https://www.nytimes.com/2022/01/20/movies/salt-in-my-soul-review.html (accessed January 26, 2023).
Land, K. J., D. I. Boeras, X. S. Chen, A. R. Ramsay, and R. W. Peeling. 2019. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nature Microbiology 4(1):46–54. https://doi.org/10.1038/s41564-018-0295-3.
Leslie, H. H., D. Spiegelman, X. Zhou, and M. E. Kruk. 2017. Service readiness of health facilities in Bangladesh, Haiti, Kenya, Malawi, Namibia, Nepal, Rwanda, Senegal, Uganda, and the United Republic of Tanzania. Bulletin of the World Health Organization 95(11):738–748. https://doi.org/10.2471/BLT.17.191916.
Lieberman, J. A., C. A. Cannon, and L. A. Bourassa. 2021. Laboratory perspective on racial disparities in sexually transmitted infections. The Journal of Applied Laboratory Medicine 6(1):264–273. https://doi.org/10.1093/jalm/jfaa163.
MAAP (Mapping AMR & AMU Partnership). 2022. Incomplete Antimicrobial Resistance (AMR) Data in Africa: The Crisis within the Crisis. https://aslm.org/wp-content/uploads/2022/09/ASLM_MAAP-Policy-Brief_Embargoed-until-15-Sept-6AM-GMT.pdf?x26552 (accessed January 31, 2023).
Marschal, M., J. Bachmaier, I. Autenrieth, P. Oberhettinger, M. Willmann, and S. Peter. 2017. Evaluation of the Accelerate Pheno System for fast identification and antimicrobial susceptibility testing from positive blood cultures in bloodstream infections caused by gram-negative pathogens. Journal of Clinical Microbiology 55(7):2116–2126. https://doi.org/10.1128/JCM.00181-17.
Messacar, K., S. K. Parker, J. K. Todd, and S. R. Dominguez. 2017. Implementation of rapid molecular infectious disease diagnostics: The role of diagnostic and antimicrobial stewardship. Journal of Clinical Microbiology 55(3):715–723. https://doi.org/10.1128/JCM.02264-16.
Miller, M. B., F. Atrzadeh, C. D. Burnham, S. Cavalieri, J. Dunn, S. Jones, C. Mathews, P. Mc-Nult, J. Meduri, C. Newhouse, D. Newton, M. Oberholzer, J. Osiecki, D. Pedersen, N. Sweeney, N. Whitfield, and J. Campos. 2019. Clinical utility of advanced microbiology testing tools. Journal of Clinical Microbiology 57(9):e00495-19. https://doi.org/10.1128/JCM.00495-19.
Molecular Devices. 2022. COVID-19 Timeline: Diagnostics, Vaccines, and Therapeutic Antibody Development. https://www.moleculardevices.com/lab-notes/clone-screening/covid-19-timeline-diagnostics-vaccines-antibody-discovery (accessed January 26, 2023).
Mukanga, D., A. B. Tiono, T. Anyorigiya, K. Källander, A. T. Konaté, A. R. Oduro, J. K. Tibenderana, L. Amenga-Etego, S. B. Sirima, S. Cousens, G. Barnish, and F. Pagnoni. 2012. Integrated community case management of fever in children under five using rapid diagnostic tests and respiratory rate counting: A multi-country cluster randomized trial. The American Journal of Tropical Medicine and Hygiene 87(5):21–29. https://doi.org/10.4269/ajtmh.2012.11-0816.
NASEM (National Academies of Sciences, Engineering, and Medicine). 2017. Combating Antimicrobial Resistance: A One Health Approach to a Global Threat: Proceedings of a Workshop. Washington, DC: The National Academies Press. https://doi.org/10.17226/24914.
NASEM. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. https://doi.org/10.17226/26350.
NRC (National Research Council). 2014. Technological Challenges in Antibiotic Discovery and Development: A Workshop Summary. Washington, DC: The National Academies Press. https://doi.org/10.17226/18616.
NIH (National Institutes of Health). 2020. Rapid diagnostic for gonorrhea wins $19 million federal prize competition to combat antibiotic resistance. https://www.nih.gov/news-events/news-releases/rapid-diagnostic-gonorrhea-wins-19-million-federal-prize-competition-combat-antibiotic-resistance (accessed January 27, 2023).
Novosad, S. A., M. R. Sapiano, C. Grigg, J. Lake, M. Robyn, G. Dumyati, C. Felsen, D. Blog, E. Dufort, S. Zansky, K. Wiedeman, L. Avery, R. B. Dantes, J. A. Jernigan, S. S. Magill, A. Fiore, and L. Epstein. 2016. Vital signs: Epidemiology of sepsis: Prevalence of health care factors and opportunities for prevention. Morbidity and Mortality Weekly Report 65(33):864–869. https://doi.org/10.15585/mmwr.mm6533e1.
OECD (Organization for Economic Co-operation and Development). 2018. Stemming the Superbug Tide: Just A Few Dollars More. OECD Publishing, Paris. https://doi.org/10.1787/9789264307599-en.
O’Neill, J. 2016. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Government of the United Kingdom. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf (accessed January 31, 2023).
PACCARB (Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria). 2017. Recommendations for Incentivizing the Development of Vaccines, Diagnostics, and Therapeutics to Combat Antibiotic-Resistance. https://www.hhs.gov/sites/default/files/paccarb-final-incentives-report-sept-2017.pdf (accessed January 24, 2023).
Ramanan, P., A. L. Bryson, M. J. Binnicker, B. S. Pritt, and R. Patel. 2017. Syndromic panel-based testing in clinical microbiology. Clinical Microbiology Reviews 31(1):e00024-17. https://doi.org/10.1128/CMR.00024-17.
Rohr, U. P., C. Binder, T. Dieterle, F. Giusti, C. G. Messina, E. Toerien, H. Moch, and H. H. Schäfer. 2016. The value of in vitro diagnostic testing in medical practice: A status report. PloS ONE 11(3):e0149856. https://doi.org/10.1371/journal.pone.0149856.
Schwaber, M. J., and Y. Carmeli. 2014. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. Clinical Infectious Diseases 58(5):697–703. https://doi.org/10.1093/cid/cit795.
Selgelid, M. J. 2007. Ethics and drug resistance. Bioethics 21(4):218–229. https://doi.org/10.1111/j.1467-8519.2006.00542.x.
Simner, P. J., C. A. Rauch, I. W. Martin, K. V. Sullivan, D. Rhoads, R. Rolf, R. She, R. J. Souers, C. Wojewoda, and R. M. Humphries. 2022. Raising the bar: Improving antimicrobial resistance detection by clinical laboratories by ensuring use of current breakpoints. Open Forum Infectious Diseases 9(3):ofac007. https://doi.org/10.1093/ofid/ofac007.
Smith, M. Salt in My Soul: An Unfinished Life. New York: Random House, 2019.
VA (U.S. Department of Veterans Affairs). 2007. VA National Campaign Takes Aim at Resistant Staph Infections. https://www.va.gov/opa/pressrel/pressrelease.cfm?id=1396 (accessed January 25, 2023).
Ventola, C. L. 2015. The antibiotic resistance crisis: Part 1: Causes and threats. Pharmacy and Therapeutics 40(4):277–283.
WHO (World Health Organization). 2016. Diagnostic Stewardship: A Guide to Implementation in Antimicrobial Resistance Surveillance Sites. https://apps.who.int/iris/bitstream/handle/10665/251553/WHO-DGO-AMR-2016.3-eng.pdf (accessed January 23, 2023).
WHO. 2019. New Report Calls for Urgent Action to Avert Antimicrobial Resistance Crisis. https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis (accessed January 19, 2023).
WHO. 2021. Antimicrobial Resistance. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance (accessed January 19, 2023).
WHO. 2022a. Lack of Innovation Set to Undermine Antibiotic Performance and Health Gains. https://www.who.int/news/item/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (accessed January 19, 2023).
WHO. 2022b. A New Understanding of Pandemic and Epidemic Risks. https://pandemichub.who.int/ (accessed January 25, 2023).
World Bank. 2017. Drug-Resistant Infections: A Threat to Our Economic Future. Washington, DC: World Bank.
Yu, K. C., V. Gupta, H. Kabler, J. A. Watts, and A. Amiche. 2022. A multicenter analysis of inpatient antibiotic use during the 2015–2019 influenza seasons in the United States: Untapped opportunities for antimicrobial stewardship. Antimicrobial Stewardship & Healthcare Epidemiology 2(1):e140. https://doi.org/10.1017/ash.2022.265.
This page intentionally left blank.
